Aileron Therapeutics, Inc. (ALRN): Price and Financial Metrics
ALRN Price/Volume Stats
| Current price | $4.00 | 52-week high | $7.42 |
| Prev. close | $4.12 | 52-week low | $1.09 |
| Day low | $3.87 | Volume | 25,500 |
| Day high | $4.16 | Avg. volume | 73,513 |
| 50-day MA | $3.27 | Dividend yield | N/A |
| 200-day MA | $3.83 | Market Cap | 86.66M |
ALRN Stock Price Chart Interactive Chart >
Aileron Therapeutics, Inc. (ALRN) Company Bio
Aileron Therapeutics is a clinical-stage biopharmaceutical company advancing a novel class of therapeutics called stapled peptides, which represent the first general solution, or "scaffold" for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. The company's lead product candidate ALRN-6924 is being evaluated in multiple clinical trials. The company was founded in 2005 and is based in Cambridge, Massachusetts.
ALRN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...